Efficacy and Safety of Anlotinib as Maintenance Treatment After First-line Chemotherapy in SCLC
Clinical trial NCT03780283 · UNKNOWN
Trial details
- NCT number
- NCT03780283
- Sponsor
- First Hospital of Shijiazhuang City
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-01
- Primary completion
- 2020-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.